Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2 alpha/androgen receptor signals

Jie Luo,Soo Ok Lee,Yun Cui,Rachel Yang,Lei Li,Chawnshang Chang

DOI: https://doi.org/10.18632/oncotarget.4515

2015-01-01

Oncotarget

Abstract:Several infiltrating cells in the tumor microenvironment could influence the cancer progression via secreting various cytokines. Here, we found the CCL5 secreted from BM-MSCs suppressed androgen receptor (AR) signals via enhancing the expression of hypoxia inducible factor 2 alpha (HIF2 alpha) in prostate cancer (PCa) cells. Mechanism dissection revealed that the increased HIF2 alpha might alter the AR-HSP90 interaction to suppress the AR transactivation, and inhibition of HIF2 alpha reversed the BM-MSCs-increased PCa stem cell population and PCa cells invasion. Importantly, CCL5 could suppress the prolyl hydroxylases (PHDs) expression, which might then lead to suppress VHL-mediated HIF2 alpha ubiquitination. Together, these results demonstrated that the CCL5 signals from infiltrating BM-MSC cells to HIF2 alpha signals within PCa cells might play a key role to increase PCa stem cell population and PCa metastasis via altering the AR signals. Targeting this newly identified CCL5/HIF2 alpha/AR axis signal axis may allow us to develop a novel way to suppress PCa metastasis.